ArticleIntestinal research2026

Antinuclear antibodies seroconversion and endoscopic response to infliximab in biologic-naive Crohn's disease: a Chinese single-center, retrospective study.

Jinlu Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.